About the Study: Among patients with acute ischemic stroke treated within 48 hours of symptom onset, intravenous loberamisal, compared with placebo, resulted in a higher proportion of patients achieving full functional outcomes at 90 days. Further studies are needed to validate these findings and establish whether the benefits could extend to a broader patient population.

A team led by Cedars-Sinai Health Sciences University investigators has identified a protein that may hide aging cells from the body’s immune system, allowing them to build up and contribute to age-related health problems.

People with autism spectrum disorder (ASD) in the United States face a 14-year deficit in life expectancy, according to a new study by researchers at Columbia University Mailman School of Public Health and University of Colorado Anschutz. The study provides one of the first large-scale estimates of age-specific death rates and life expectancy among people with ASD.

About the Study: In this exploratory analysis of the KEYNOTE-826 randomized clinical trial, the 5-year data confirm the durability of benefit and reinforce pembrolizumab plus chemotherapy (with or without bevacizumab) as a first-line standard-of-care option for recurrent and metastatic cervical cancer.

About the Study: This Perspective explores key developments in care delivery and clinical understanding of the population exposed to the 9/11 terrorist attacks through data from the World Trade Center Health Program.

An international team of experts has issued specific recommendations for population-wide screening of children for type 1 diabetes. The consensus paper, published in the journal Diabetologia, sets out when children should be tested and how a diagnosis can be confirmed step by step through a series of tests. The aim is to identify type 1 diabetes reliably before symptoms appear, reduce the risk of severe metabolic complications and enable timely treatment and support.

A University of Minnesota Medical School research team has been awarded up to $6 million from the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, to develop more effective treatments for people with severe mental health issues, including thoughts of suicide. 

The National Science Foundation (NSF) has awarded environmental health sciences associate professor Eric Vejerano a grant of nearly $620,000 to determine how and why common sunscreen ingredients form persistent free radicals (PFRs) when they are exposed to light. Funded through the NSF’s Chemical, Bioengineering, Environmental and Transport Systems Nanoscale Interactions Program, the project names Vejerano as sole principal investigator and follows directly from his lab’s recent discovery that every commercial sunscreen it tested produced these long-lived radicals under artificial light.